A therapeutic agent containing quince GEL effective for endometriosis
Patent Information
- Application Number
- PCT/TR2023/051068
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-10-03
- Publication Date
- 2024-12-05
Smart Images

Figure 000001 
Figure 000002 
Figure 000003
Abstract
Description
[0001] A THERAPEUTIC AGENT CONTAINING QUINCE GEL EFFECTIVE FOR ENDOMETRIOSIS
[0002] TECHNICAL FIELD
[0003] The invention is based on effective therapeutic agent for endometriosis containing quince gel, thymoquinone and hesperidin, whose protective properties have been proven in the literature. By using this agent, cellular degeneration can be prevented and mucosal regeneration can be improved. Thus, considering the antioxidative effect of the agent, it is possible to prevent the development of uterine cancer.
[0004] BACKGROUND
[0005] Early detection and treatment of endometrial hyperplasia (EH) is important for the prevention of endometrial cancer. Endometrial hyperplasia (EH) is an uncontrolled form of proliferation in the uterine endometrial gland and, if left untreated, can progress to endometrial adenocarcinoma (EC). Continuous induction of estrogen to endometrium causes progression of normal endometrial proliferation to endometrial hyperplasia, a common precursor to endometrial cancer. This exposure to unopposed estrogen has been reported to induce the inflammatory response in the uterus, as inflammation may be a contributing factor to the onset and progression of EH by promoting the release of cytokines that facilitate cellular proliferation.
[0006] AIM OF THE INVENTION
[0007] One aim of the invention is to block signaling pathways and reorganize the uterine mucosa by using agent of invention with therapeutic antioxidants. Thus, further progression of uterine cancer can be prevented.
[0008] Another aim of the invention is to turn the effects of quince gel, thymoquinone and hesperidin against endometrial cancer formation into an agent ingredient, as determined by the analysis of biochemical, histopathological, immunohistochemical and ultrastructural techniques in preventing oxidative stress.
[0009] Another purpose of the invention is to create a gel-like coating in the endometrium mucosa by injecting quince gel into the vaginal area after the formation of endometriosis and to obtain an agent that will ensure the diffusion of quince gel into the mucosa. Considering that quince seed provides an antioxidative effect, in addition to this, it also works vaginally with powerful antioxidants such as thymoquinone and hesperetin to reduce inflammation caused by oxidative stress and prevent the signal that causes damage.
[0010] DETAILED DESCRIPTION OF THE INVENTION
[0011] It is known that quince seeds contain antioxidants such as phenolic compounds, citric, ascorbic and malic acid, as well as various amino acids. The beans also contain a mucinous material that can be extracted after mixing with water. Within the scope of the invention, in order to benefit from these properties of quince, a gel was prepared by mixing 10 quince seeds into approximately 10cc of water.
[0012] In literature research, the protective effects of quince fruit / seeds / plant have been observed in many organs. The agent subject to our invention was included in its content, considering its antioxidant effect and gel-like feature, and as a technical effect, due to its contribution to uterine mucosal regeneration. It is known that the variations of quince seed in different regions contain phenolic compounds and ascorbic acid, which highlights its antioxidant properties. It has also been described in the literature that the aqueous extract of quince fruit protects the gastric mucosa by suppressing gastric acid secretion and pepsin activity in the treatment of gastric ulcer.
[0013] Black cumin is a widely used herb in Turkish cuisine today. It can be used in soups, salads and appetizers, as well as in making cakes, pastries and pastries. It can be said that black cumin is taken into the body by everyone, directly or indirectly. The most bioactive substance of black cumin is thymoquinone. Thymoquinone (TQ) supports cell life and antioxidant system by inducing growth factors, anti-oxidant enzymes and DNA repair enzymes. Thymoquinone also inhibits the STAT3 molecule, one of the cytokines, preventing the activation of the apoptotic pathway and stopping cell death. Thymoquinone also inhibits cancer by regulating the JNK and p38 signaling pathways. Thymoquinone is a phytochemical compound and belongs to the p- benzoquinone group. It has a biologically active structure due to the C=O (carbonyl) groups in its structure. In our study, thymoquinone was chosen for this percentage. In our study, the thymoquinone dose was preferably determined as 50 mg / kg. The reason for determining this dose is that thymoquinone has low toxicity at this dose. Thymoquinone, which is given orally or intraperitoneally in the literature, was given intravaginally in our invention and its reaction directly to the uterine tissue was achieved.
[0014] Hesperidin is a compound belonging to the flavonoid group that contains phenolic compounds in its structure. Flavonoids are phytochemical compounds. Hesperidin (HPD) supports antioxidant defense by inducing antioxidant enzymes GSH, CAT and SOD. HPD inactivates the pro-apoptotic BAX protein by inhibiting the AMPK signaling pathway. Thus, it stops apoptotic cell deaths. HPD also stops the inflammation pathway by inhibiting the inflammatory cytokine Tnfa. It participates in electron transport chain and oxidation reactions due to the phenolic compounds it contains. Hesperidin is a flavonoid found especially in citrus fruits. Considering that our country, especially the Mediterranean region, is rich in citrus fruits and takes part in world production, it is observed that it is easy and cheap for our people to access hesperidin. It is also known that hesperidin is also found in supplement pills. In our study, the dose of hesperidin was preferably determined as 150 mg / kg. This is because the 150 mg / kg dose level is the most optimum dosage. Oral intake of hesperidin is more preferred. However, within the scope of our invention, it is directly interacted with the uterine tissue.
[0015] When quince seeds are examined, it is seen that they contain the phenolic components listed below:
[0016] • 3-O-caffeoylquinic,
[0017] • 4-O-caffeoylquinic,
[0018] • 5-O-caffeoylquinic
[0019] • 3,5-dicaffeoylquinic acids
[0020] • Lucenin-2
[0021] • Vicenin-2
[0022] • Stellarin-2
[0023] • Isoschaftoside
[0024] • Schaftoside,
[0025] • 6-C-pentosyl-8-C-glucosyl chrysoeriol
[0026] • 6-C-glucosyl-8-C-pentosyl chrysoeriol
[0027] Quince gel seed has a bioactive structure due to the phenolic compounds listed above. Within the scope of our invention, quince seed gel was obtained by soaking quince seeds in water. It is known that the gel consistency is used in wound and burn healing. Due to its gel structure, it covers the surface of the relevant area and prevents it from coming into contact with air. It has been observed that the treatment agents recommended especially for burn and scar healing are based on this logic. In this context, within the scope of our invention, the thymoquinone and hesperidin-containing agent added to quince seed gel is designed to be used intravaginally.
[0028] The technical effect of creating the thymoquinone and hesperidin containing agent added to the quince seed gel, which is the subject of our invention, with this content; thymoquinone contains carbonyl groups and reacts with many cellular events in the body; The antioxidant and anti-inflammatory properties of hesperidin are known and quince seeds can naturally form a gel consistency. In addition, features such as the widespread availability of the active ingredients used in the agent in our country, easy direct or indirect access, and cheapness were also taken into consideration as technical effects.
[0029] Quince leaves and seeds showed antiproliferative effects on human cancer cells in colon and kidney cancers. Caffeoylquinic acid derivatives, such as 5-0- caffeoylquinic acid found in quince, have been shown to inhibit growth and induce apoptosis in several human cancer cell lines. Quince caffeoylquinic acids prevent and treat cancer by inhibiting growth factors such as interferon-y, interleukin-2, extracellular signal-regulated protein kinase1 / 2, serine / threonine protein kinase, NF-kB and inducible nitric oxide synthase. It has been reported that quince membrane prevents lipid peroxidation, mitochondrial swelling, mitochondrial membrane potential collapse (%AMJm) and cytochrome c release.
[0030] It has been described in the literature that thymoquinone is as effective as superoxide dismutase against superoxides because it inhibits lipid peroxidation and acts as a powerful superoxide radical scavenger. It is also known that thymoquinone increases the mRNA expression of genes that control the production of antioxidant enzymes such as SOD, catalase (CAT), gutathione peroxidase (G-Px) and glutathione- S-peroxidase. Thymoquinone can inhibit the expression of inducible nitric oxide synthase (iNOS), which plays a role in oxidative stress, and increase the expression of antioxidant enzymes such as glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Moreover, substrate utilization and / or oxidative phosphorylation is significantly induced by thymoquinone, and mitochondrial It has been reported that it also increases the production of more energy (ATP) by increasing function.
[0031] Hesperetin demonstrated potent antioxidant effects by scavenging elevated ROD and enhancing endogenous antioxidant defense mechanisms, particularly by regulating the expression of the transcription factor nuclear factor-2 erythroid-2 (Nrf2) and its target heme oxygenase-1 (HO-1 ). In one study, oxidative stress was induced by H2O2 in RPE-19 cells and treated with hesperetin. The results showed that hesperetin significantly protected RPE-19 cells from high oxidative stress by inhibiting apoptotic cell death (by regulating the expression of Bax, Bcl2, and caspase-3), ROS and MDA production, and increasing their expression. It has been reported that it reduces the level of MDA, a marker of oxidative stress, and also increases the levels of CAT and GSH-Px, which are important members of antioxidant enzyme systems.
[0032] Hesperidin inhibits high glucose-mediated cell loss and reverses the loss of mitochondrial membrane potential and cytochrome c release and restores mitochondrial function. In treatment with hesperidin, the high glucose-induced increase in ROS, malondialdehyde and protein carbonyl levels is blocked in retinal ganglial cells (RGC-5) cells.
[0033] Hesperidin increases superoxide dismutase, catalase, glutathione peroxidase activities and restores glutathione levels. Hesperidin inhibits high glucose-induced cell apoptosis by attenuating the downregulation of caspase-9, caspase-3 and Bax / Bcl-2. Furthermore, phosphorylation of c-Jun N-terminal kinases (JNK) and p38 MAPK triggered by high glucose is attenuated in RGC-5 cells after incubation with hesperdin.
Claims
CLAIMS1. An effective therapeutic agent for endometriosis that is administered intravaginally and reacts directly with the uterine tissue characterized by comprising quince seed gel, thymoquinone and hesperidin.
2. The agent according to claim 1 characterized by comprising 50mg / kg of thymoquinone.
3. The agent according to claim 1 and characterized by comprising 150mg / kg of hesperidin.
